Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

19.03.18	BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent (PR Newswire)
12.03.18	Biogen To Acquire Phase 2b Ready Asset For Schizophrenia (RTTNews)
09.03.18	FDA Panel Backs Xeljanz For UC, ACRX Abuzz, AGLE Awaits Data This Month (RTTNews)
08.03.18	FDA Panel Backs Pfizer's Xeljanz For Ulcerative Colitis (RTTNews)
08.03.18	Pfizer Announces Favorable Outcome of FDA Advisory Committee Meeting on XELJANZ® (tofacitinib) for Moderately to Severely Active Ulcerative Colitis (Businesswire)
07.03.18	Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference (Businesswire)
05.03.18	Dan R. Littman Elected to Pfizer’s Board of Directors (Businesswire)
05.03.18	ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-Infected With Tuberculosis (PR Newswire)
04.03.18	An Ear To The Pharma: 7 Stocks To Watch This Week (RTTNews)
02.03.18	Neofluidics Enters Collaboration With Pfizer - Quick Facts (RTTNews)
02.03.18	Neofluidics Announces Collaboration with Pfizer Inc. (PR Newswire)
27.02.18	Biotech Stocks Facing FDA Decision In March (RTTNews)
23.02.18	Pfizer Gets Positive CHMP Opinion For Mylotarg And Bosulif - Quick Facts (RTTNews)
23.02.18	Pfizer Updates On EMA Application For SUTENT (RTTNews)
23.02.18	Pfizer Announces Update on European Marketing Authorization Application for SUTENT® (sunitinib) in Adult Patients at High Risk of Recurrent Renal Cell Carcinoma (Businesswire)
23.02.18	Albert Bourla Elected to Pfizer’s Board of Directors (Businesswire)
15.02.18	Merck: Phase III JAVELIN Lung 200 Trial With Avelumab Fails To Meet Endpoint (RTTNews)
14.02.18	Pfizer Receives Breakthrough Therapy Designation For PF-04965842 - Quick Facts (RTTNews)
14.02.18	Pfizer Receives Breakthrough Therapy Designation from FDA for PF-04965842, an oral JAK1 Inhibitor, for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis (Businesswire)
13.02.18	Success Of Mow N' Stow® Technology Leads To Expanded Offering (PR Newswire)
12.02.18	U.S., EU, Japan Accept Regulatory Submissions For Review Of Pfizer's Lorlatinib (RTTNews)
08.02.18	ViiV Files Patent Infringement Lawsuit Against Gilead Sciences On Bictegravir (RTTNews)
06.02.18	Xtandi Prospers, One Down, One To Go For AMAG, There's Reason For CORT's Fall (RTTNews)
05.02.18	Phase 3 PROSPER Trial Shows XTANDI® (enzalutamide) Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer (Businesswire)
05.02.18	Phase 3 PROSPER Trial Shows XTANDI® (enzalutamide) Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer (PR Newswire)
05.02.18	Bloomberg: Glaxo, Reckitt Submit Bids For Pfizer's Consumer Business Unit (RTTNews)
30.01.18	IIROC Trading Resumption - PERU (PR Newswire)
30.01.18	Pfizer Q4 Results Beat Estimates; Issues Upbeat FY18 Outlook (RTTNews)
30.01.18	Pfizer Inc. Earnings Climb In Q4 (RTTNews)
30.01.18	PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS (Businesswire)
24.01.18	Pfizer: Potential Biosimilar To Rituxan Meets Primary Endpoint - Quick Facts (RTTNews)
24.01.18	Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera® (Businesswire)
22.01.18	Some Branded Drugs Going Generic In 2018 (RTTNews)
16.01.18	Foundation Medicine, Pfizer Enter Into Broad Tie-up For Companion Diagnostics (RTTNews)
16.01.18	The Race To Find A Treatment For NASH (RTTNews)
11.01.18	Novartis Names Elizabeth Barrett CEO, Novartis Oncology - Quick Facts (RTTNews)
08.01.18	Pfizer Inc. Announces Expiration and Results of its Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents (Businesswire)
08.01.18	Pfizer Establishes New Partnering Model for Early-Stage Academic Research (Businesswire)
08.01.18	Pfizer Ends Alzheimer's And Parkinson's Research; To Cut 300 Jobs (RTTNews)
07.01.18	New Drugs Approved In December (RTTNews)
04.01.18	Berkeley Lights Announces Research Collaboration and License Agreement with Pfizer (PR Newswire)
04.01.18	Arvinas Sees $830 Mln Upfront, Potential Milestone Payments In Deal With Pfizer (RTTNews)
04.01.18	Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug Candidates (PR Newswire)
03.01.18	Sangamo, Pfizer Collaborate On Zinc Finger Protein Gene Therapy For ALS (RTTNews)
03.01.18	Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS (PR Newswire)
27.12.17	Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference (Businesswire)
24.12.17	It's Raining FDA Approvals, SMMT Opens Wallet, AGRX Snubbed Yet Again (RTTNews)
22.12.17	Merck, Pfizer: FDA Approves Steglatro And Fixed-dose Combination Steglujan (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

17:02		Roche-Aktie unter Druck: Roche erleidet in Lungenkrebs-Studie Forschungsrückschlag - Poseida-Übernahme
16:02		Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?
16:02		S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen
16:02		Schwacher Handel in New York: Dow Jones zum Start mit Abgaben
15:58		Minuszeichen in Europa: Euro STOXX 50 schwächer
15:58		Schwache Performance in London: FTSE 100 sackt nachmittags ab
15:58		Schwacher Handel: SPI verliert
15:58		Handel in Frankfurt: LUS-DAX schwächelt

17:02

Roche-Aktie unter Druck: Roche erleidet in Lungenkrebs-Studie Forschungsrückschlag - Poseida-Übernahme

16:02

Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?

16:02

S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen

16:02

Schwacher Handel in New York: Dow Jones zum Start mit Abgaben

15:58

Minuszeichen in Europa: Euro STOXX 50 schwächer

15:58

Schwache Performance in London: FTSE 100 sackt nachmittags ab

15:58

Schwacher Handel: SPI verliert

15:58

Handel in Frankfurt: LUS-DAX schwächelt

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.55	1.16 %	K V
Lonza Grp	531.60	0.95 %	K V
Logitech Intl	72.30	0.14 %	K V
Zurich Insur Gr	552.00	0.00 %	K V
Swiss Life Hldg	718.40	-0.96 %	K V
Swisscom	503.50	-1.08 %	K V
ABB	49.42	-1.08 %	K V
Holcim	88.34	-1.60 %	K V
UBS Group	27.73	-2.19 %	K V

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten